Recruiting Prurigo Nodularis Studies in Ann Arbor
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform trial for community-acquired pneumonia. The purpose of this study is to evaluate the effect of a range of interventions to impro...
Down Syndrome Obstructive Sleep Apnea
The purpose of this study is to assess whether oxygen supplementation during sleep improves working memory and other clinical and patient-reported outcomes among children who have Down Syndrome (DS) w...
About Prurigo Nodularis Clinical Trials in Ann Arbor
Prurigo nodularis is a chronic skin condition characterized by intensely itchy, hard lumps on the skin that develop from repeated scratching. It significantly impacts quality of life and sleep. Treatment includes topical therapies, phototherapy, and newer targeted biologics.
There are currently 2 prurigo nodularis clinical trials recruiting participants in Ann Arbor, MI. These studies are seeking a combined 20,230 participants. Research is being sponsored by UMC Utrecht, Brigham and Women's Hospital. Clinical trial participation is free and participants receive study-related medical care at no cost.
Prurigo Nodularis Clinical Trials in Ann Arbor — FAQ
Are there prurigo nodularis clinical trials in Ann Arbor?
Yes, there are 2 prurigo nodularis clinical trials currently recruiting in Ann Arbor, MI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Ann Arbor?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you about next steps.
Are clinical trials in Ann Arbor free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ann Arbor studies also compensate for your time and travel.
What prurigo nodularis treatments are being tested?
The 2 active trials in Ann Arbor are testing new therapies including novel drugs, biologics, and treatment approaches for prurigo nodularis.
Data updated March 2, 2026 from ClinicalTrials.gov